This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Adaptive Phage Therapeutics, Inc.. Active years: 2024.
Company Filing History:
Years Active: 2024
Title: Jarrar Haider: Innovator in Bacteriophage Purification
Introduction
Jarrar Haider is a notable inventor based in Columbia, MD (US). He has made significant contributions to the field of bacteriophage research, particularly in the purification of phage particles. His innovative methods have the potential to impact therapeutic applications significantly.
Latest Patents
Jarrar Haider holds a patent for a "Method for purification of bacteriophage particles." This method involves recovering viable phage from crude phage preparations, such as lysates resulting from amplification in bacterial cell culture. The technique is designed to be universal, applicable to a broad range of phage species and strains. The resulting phage product boasts an acceptably low endotoxin titer, specifically less than 500 EU/ml, and a sufficiently high phage titer, exceeding 1×10 PFU/ml, making it suitable for therapeutic uses.
Career Highlights
Jarrar Haider is associated with Adaptive Phage Therapeutics, Inc., where he continues to advance his research and development efforts. His work focuses on harnessing the therapeutic potential of bacteriophages, which are viruses that infect bacteria.
Collaborations
Some of his notable coworkers include Joseph Robert Fackler and Carl Merril, who contribute to the collaborative efforts in the field of bacteriophage research.
Conclusion
Jarrar Haider's innovative work in bacteriophage purification represents a significant advancement in therapeutic applications. His contributions are paving the way for new treatments and methodologies in the field.